(Q34481305)

2 August 2017

1 reference

title

Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

J K McGavin

1

1 reference

2 August 2017

K L Goa

series ordinal

2

1 reference

2 August 2017

publication date

1 January 2001

1 reference

2 August 2017

1 reference

2 August 2017

volume

61

1 reference

2 August 2017

issue

15

1 reference

2 August 2017

page(s)

2309-2326

1 reference

Severe ocular irritation and corneal deposits associated with capecitabine use

2 August 2017

cites work

1 reference

12 December 2020

Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine

1 reference

12 December 2020

Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts

1 reference

12 December 2020

Mechanism of action of fluoropyrimidines: relevance to the new developments in colorectal cancer chemotherapy.

1 reference

12 December 2020

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study

1 reference

12 December 2020

Capecitabine: preclinical pharmacology studies

1 reference

12 December 2020

1 reference

12 December 2020

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

12 December 2020

Patient preferences for oral versus intravenous palliative chemotherapy

1 reference

12 December 2020

Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study

1 reference

12 December 2020

Estimates of the worldwide incidence of 25 major cancers in 1990.

1 reference

12 December 2020

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

1 reference

12 December 2020

Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study

1 reference

12 December 2020

Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer

1 reference

12 December 2020

Clinical pharmacokinetics of capecitabine

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients

1 reference

12 December 2020

Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites

1 reference

12 December 2020

ABC of colorectal cancer: Epidemiology

1 reference

12 December 2020

A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug

1 reference

12 December 2020

Mechanisms and therapeutic implications of angiogenesis

1 reference

12 December 2020

Warfarin-5-FU interaction--a consecutive case series

1 reference

12 December 2020

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

12 December 2020

Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

1 reference

12 December 2020

Oral fluoropoyrimidines

1 reference

12 December 2020

Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients

1 reference

12 December 2020

X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts

1 reference

12 December 2020

Estimates of the worldwide mortality from 25 cancers in 1990.

1 reference

12 December 2020

Fluoropyrimidines in the treatment of advanced neoplastic diseases: role and advantages of UFT.

1 reference

12 December 2020

Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer

1 reference

12 December 2020

A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors

1 reference

12 December 2020

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer

1 reference

12 December 2020

Novel oral fluoropyrimidines in the treatment of metastatic colorectal cancer.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

1 reference

12 December 2020

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

1 reference

12 December 2020

Irinotecan. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer

1 reference

12 December 2020

The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine

1 reference

12 December 2020

10.2165/00003495-200161150-00015

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

1032019211

0 references

1 reference